Clinical Trial Update: A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions [Phase 4]

View source ↗

Summary

Cordis US Corp. conducted a Phase 4 clinical trial in diabetic patients with de novo native coronary artery lesions. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED